Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
An approachable overview comparing passive retirement investing using index funds versus ETFs, highlighting costs, flexibility, and long-term potential.
25,610 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
PepsiCo stock faces a potential move toward $180 as analysts cite World Cup-driven demand, cost cuts, and internation...
President Trump launches a Department of Justice probe into gasoline pricing after asserting that consumers are being...
Counterfeit money can slip into everyday transactions and end up funding gift cards via fraud. This guide explains th...
Bitcoin traded near $59,000 after briefly dipping below $60,000, triggering a wave of skeptics and a robust counter-n...
Investors are shifting from FXI to a South Korea-focused ETF to capture the AI hardware boom, citing lower costs and ...
Strategy confronts a $12 billion unrealized loss on its bitcoin holdings as Bitcoin trades around $60,000, tightening...
FuelCell Energy surges on a major data-center deal, while Bloom Energy retreats, underscoring a rare divergence in th...
A leading bank projects XRP could reach $28 by 2030, even as Ripple pushes a new stablecoin. The forecast highlights ...
Micron Technology faces a pivotal moment as AI memory demand accelerates. Analysts weigh a potential multi-year upcyc...
Wells Fargo analysts expect a constructive stretch for U.S. equities into the warmer months, provided volatility stay...
Open Standard announces Open USD, a new stablecoin backed by 140 plus firms including Stripe and Visa, set to launch ...